1.
Augustin M, Weglowska J, Lebwohl M, Paul C, Piquet V, Sofen H, Blauvelt A, Burge D, Peterson L, Drew J, Rollen R. Maintenance of Response with Certolizumab Pegol for the Treaatment of Chronic Plaque Psoriasis: Results of a 32-Week Re-Randomized Maintenance Period from an Onging Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT). J of Skin [Internet]. 2017Oct.27 [cited 2024Apr.14];1(3.1):s24. Available from: https://www.jofskin.org/index.php/skin/article/view/119